The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis
- 25 May 2007
- book chapter
- Published by Elsevier
- Vol. 79, 43-72
- https://doi.org/10.1016/s0074-7742(07)79003-7
Abstract
No abstract availableKeywords
This publication has 189 references indexed in Scilit:
- Selective regulatory function of Socs3 in the formation of IL-17-secreting T cellsProceedings of the National Academy of Sciences, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's DiseaseNew England Journal of Medicine, 2005
- T cell vaccination in multiple sclerosis relapsing–remitting nonresponders patientsClinical Immunology, 2004
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.The Journal of Experimental Medicine, 1995